Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06194643 · ClinicalTrials.gov registry record
Platelets in Pregnancy
A clinical trial of Hypertensive Disorder of Pregnancy, sponsored by NYU Langone Health.
- Active
- Registry status
- 66
- Enrollment target
- 1
- Study location
NCT06194643: Active study of Hypertensive Disorder of Pregnancy, sponsored by NYU Langone Health.
NCT06194643 is a study of Hypertensive Disorder of Pregnancy that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 66 participants, below the 2,691-participant average among 8 other Hypertensive Disorder of Pregnancy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06194643, a study of Hypertensive Disorder of Pregnancy, is active but no longer recruiting, sponsored by NYU Langone Health.
- ACTIVE NOT RECRUITING
- Registry status
- 66 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective observational cohort study of platelet phenotype in pregnant patients at high-risk for the development preeclampsia. Blood samples will be collected prior to the initiation of daily aspirin and again in the second trimester to evaluate for platelet changes during pregnancy in patient's as a result of aspirin use and their association with adverse perinatal outcomes.
Conditions Studied
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2023-01-17 |
| Est. Completion | 2026-03 |
What the registry record for NCT06194643 still lists
NCT06194643 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 2,691-participant average among 8 other Hypertensive Disorder of Pregnancy trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Hypertensive Disorder of Pregnancy appearing as the primary indexed condition, and to 0 interventions.
NCT06194643 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06194643 about?
NCT06194643 is a clinical study titled "Platelets in Pregnancy". This is a prospective observational cohort study of platelet phenotype in pregnant patients at high-risk for the development preeclampsia. Blood samples will be collected prior to the initiation of daily aspirin and again in the second trimester to evaluate for platelet changes during pregnancy in p...
What is the current status of trial NCT06194643?
This trial is currently active not recruiting. The enrollment target is 66 participants. The study started on 2023-01-17. Estimated completion is 2026-03.
What conditions does trial NCT06194643 study?
This clinical trial studies the following conditions: Hypertensive Disorder of Pregnancy.
Who is sponsoring clinical trial NCT06194643?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06194643 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertensive Disorder of Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06194643's enrollment target sits among peer trials
66 7th of 8 higher than 2 of 8 other Hypertensive Disorder of Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertensive Disorder of Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Treatment With Aspirin After Preeclampsia: TAP Trial
RECRUITING · Phase 4
-
HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring
RECRUITING · NA
-
The ACHIEVE Trial: Achieving Longer Gestation in Preeclampsia Via Antihypertensive Therapy.
RECRUITING · NA
-
The Preeclampsia Registry
RECRUITING
-
Microbial Metabolites and Outcomes of Pregnancy Study
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI